{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T04:18:19Z","timestamp":1769573899334,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["2021xkj104"],"award-info":[{"award-number":["2021xkj104"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.tranon.2023.101816","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T05:27:33Z","timestamp":1698989253000},"page":"101816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Comprehensive analysis of ASB3 as a prognostic biomarker in hepatocellular carcinoma"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7334-474X","authenticated-orcid":false,"given":"Zhongqiang","family":"Qin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangquan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peipei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianzhu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longfei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuaishuai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8532-2935","authenticated-orcid":false,"given":"Jingyu","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.tranon.2023.101816_bib0001","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.tranon.2023.101816_bib0002","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.tranon.2023.101816_bib0003","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2188\/jea.JE20100190","article-title":"Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures","volume":"21","author":"Tanaka","year":"2011","journal-title":"J. Epidemiol."},{"issue":"1","key":"10.1016\/j.tranon.2023.101816_bib0004","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12943-018-0769-1","article-title":"Targeting Gas6\/TAM in cancer cells and tumor microenvironment","volume":"17","author":"Wu","year":"2018","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2023.101816_bib0005","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.humimm.2021.09.004","article-title":"Exhausted NK cells and cytokine storms in COVID-19: whether NK cell therapy could be a therapeutic choice","volume":"83","author":"Ghasemzadeh","year":"2022","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.tranon.2023.101816_bib0006","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0065-2776(08)60664-1","article-title":"Biology of natural killer cells","volume":"47","author":"Trinchieri","year":"1989","journal-title":"Adv Immunol."},{"issue":"7","key":"10.1016\/j.tranon.2023.101816_bib0007","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.humimm.2022.04.010","article-title":"HLA-E*01:01 allele is associated with better response to anti-HCV therapy while homozygous status for HLA-E*01:03 allele increases the resistance to anti-HCV treatments in frequently transfused thalassemia patients","volume":"83","author":"Hosseini","year":"2022","journal-title":"Hum. Immunol."},{"issue":"5","key":"10.1016\/j.tranon.2023.101816_bib0008","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/CAD.0000000000000902","article-title":"Outcomes in hepatocellular carcinoma patients undergoing sorafenib treatment: toxicities, cellular oxidative stress, treatment adherence, and quality of life","volume":"31","author":"Baldan Ferrari","year":"2020","journal-title":"Anticancer Drugs"},{"issue":"34","key":"10.1016\/j.tranon.2023.101816_bib0009","doi-asserted-by":"crossref","first-page":"7645","DOI":"10.3748\/wjg.v22.i34.7645","article-title":"Challenges of advanced hepatocellular carcinoma","volume":"22","author":"Colagrande","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"28","key":"10.1016\/j.tranon.2023.101816_bib0010","doi-asserted-by":"crossref","first-page":"8478","DOI":"10.3748\/wjg.v21.i28.8478","article-title":"Current and future treatments for hepatocellular carcinoma","volume":"21","author":"Schlachterman","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.tranon.2023.101816_bib0011","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/gutjnl-2014-308139","article-title":"Liver resection for patients with hepatocellular carcinoma and macrovascular invasion, multiple tumours, or portal hypertension","volume":"64","author":"Zhong","year":"2015","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.tranon.2023.101816_bib0012","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2016.5059","article-title":"Effect of background liver cirrhosis on outcomes of hepatectomy for hepatocellular carcinoma","volume":"152","author":"Sasaki","year":"2017","journal-title":"JAMA Surg"},{"issue":"5","key":"10.1016\/j.tranon.2023.101816_bib0013","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jhep.2009.07.009","article-title":"Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma","volume":"51","author":"Wu","year":"2009","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.tranon.2023.101816_bib0014","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00534-009-0244-x","article-title":"Single HCC smaller than 2 cm: surgery or ablation: interventional oncologist's perspective","volume":"17","author":"Livraghi","year":"2010","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"10","key":"10.1016\/j.tranon.2023.101816_bib0015","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.tranon.2023.101816_bib0016","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.tranon.2023.101816_bib0017","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-018-0804-2","article-title":"Kinase-targeted cancer therapies: progress, challenges and future directions","volume":"17","author":"Bhullar","year":"2018","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2023.101816_bib0018","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1186\/s13046-019-1412-8","article-title":"Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma","volume":"38","author":"Liu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"10088","key":"10.1016\/j.tranon.2023.101816_bib0019","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/S0140-6736(17)31046-2","article-title":"Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1\/2 dose escalation and expansion trial","volume":"389","author":"El-Khoueiry","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.tranon.2023.101816_bib0020","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrd.2015.35","article-title":"Development of immuno-oncology drugs - from CTLA4 to PD1 to the next generations","volume":"15","author":"Hoos","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.tranon.2023.101816_bib0021","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/hep.27222","article-title":"Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?","volume":"60","author":"El-Serag","year":"2014","journal-title":"Hepatology"},{"issue":"30","key":"10.1016\/j.tranon.2023.101816_bib0022","doi-asserted-by":"crossref","first-page":"6796","DOI":"10.1016\/j.febslet.2005.11.016","article-title":"ASB proteins interact with Cullin5 and Rbx2 to form E3 ubiquitin ligase complexes","volume":"579","author":"Kohroki","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tranon.2023.101816_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13008-016-0016-3","article-title":"The role of cullin 5-containing ubiquitin ligases","volume":"11","author":"Okumura","year":"2016","journal-title":"Cell Div"},{"issue":"5","key":"10.1016\/j.tranon.2023.101816_bib0024","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.7150\/ijbs.31484","article-title":"ASB6 Promotes the Stemness Properties and Sustains Metastatic Potential of Oral Squamous Cell Carcinoma Cells by Attenuating ER Stress","volume":"15","author":"Hung","year":"2019","journal-title":"Int J Biol Sci"},{"issue":"19\u201320","key":"10.1016\/j.tranon.2023.101816_bib0025","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1101\/gad.339796.120","article-title":"ASB13 inhibits breast cancer metastasis through promoting SNAI2 degradation and relieving its transcriptional repression of YAP","volume":"34","author":"Fan","year":"2020","journal-title":"Genes Dev."},{"issue":"5","key":"10.1016\/j.tranon.2023.101816_bib0026","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"issue":"4","key":"10.1016\/j.tranon.2023.101816_bib0027","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.tranon.2023.101816_bib0028","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra1001683","article-title":"Hepatocellular carcinoma","volume":"365","author":"El-Serag","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.tranon.2023.101816_bib0029","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/onc.2010.594","article-title":"Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer","volume":"30","author":"McGivern","year":"2011","journal-title":"Oncogene"},{"issue":"18","key":"10.1016\/j.tranon.2023.101816_bib0030","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1007\/s00018-016-2255-5","article-title":"The recognition of ubiquitinated proteins by the proteasome","volume":"73","author":"Grice","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.tranon.2023.101816_bib0031","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2016.06.020","article-title":"Post-Translational Modification Control of Innate Immunity","volume":"45","author":"Liu","year":"2016","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.tranon.2023.101816_bib0032","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/onc.2009.343","article-title":"Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells","volume":"29","author":"Zhu","year":"2010","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.tranon.2023.101816_bib0033","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1042\/BJ20140006","article-title":"RBR E3 ubiquitin ligases: new structures, new insights, new questions","volume":"458","author":"Spratt","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.tranon.2023.101816_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.842524","article-title":"Pan-cancer analysis of ASB3 and the potential clinical implications for immune microenvironment of glioblastoma multiforme","volume":"13","author":"Mu","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.tranon.2023.101816_bib0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40880-017-0180-0","article-title":"The loss-of-function mutations and down-regulated expression of ASB3 gene promote the growth and metastasis of colorectal cancer cells","volume":"36","author":"Du","year":"2017","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.tranon.2023.101816_bib0036","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cellimm.2015.09.011","article-title":"Tolerance and immune suppression in the tumor microenvironment","volume":"299","author":"Ostrand-Rosenberg","year":"2016","journal-title":"Cell. Immunol."},{"issue":"4","key":"10.1016\/j.tranon.2023.101816_bib0037","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1189\/jlb.0304197","article-title":"Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis","volume":"76","author":"Ahmad","year":"2004","journal-title":"J Leukoc Biol"},{"issue":"3","key":"10.1016\/j.tranon.2023.101816_bib0038","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1189\/JLB.0309135","article-title":"Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases","volume":"86","author":"Gao","year":"2009","journal-title":"J Leukoc Biol"},{"issue":"3","key":"10.1016\/j.tranon.2023.101816_bib0039","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jaci.2013.07.020","article-title":"Natural killer cell deficiency","volume":"132","author":"Orange","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"26","key":"10.1016\/j.tranon.2023.101816_bib0040","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJM198906293202605","article-title":"Severe herpesvirus infections in an adolescent without natural killer cells","volume":"320","author":"Biron","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tranon.2023.101816_bib0041","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.4049\/jimmunol.172.12.7335","article-title":"Elevated TGF-\u03b21 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients","volume":"172","author":"Lee","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.tranon.2023.101816_bib0042","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1158\/0008-5472.CAN-12-1993","article-title":"Zhang Jet al. Preventing postoperative metastatic disease by inhibiting surgery-induced dysfunction in natural killer cells","volume":"73","author":"Tai","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.tranon.2023.101816_bib0043","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1172\/JCI74337","article-title":"Cytokine therapy reverses NK cell anergy in MHC-deficient tumors","volume":"124","author":"Ardolino","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tranon.2023.101816_bib0044","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1245\/s10434-018-6691-3","article-title":"Natural killer cell IFN\u03b3 secretion is profoundly suppressed following colorectal cancer surgery","volume":"25","author":"Angka","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.tranon.2023.101816_bib0045","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.3389\/fmicb.2018.03097","article-title":"Respiratory viral infections in patients with cancer or undergoing hematopoietic cell transplant","volume":"9","author":"Hijano","year":"2018","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.tranon.2023.101816_bib0046","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.tranon.2023.101816_bib0047","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jaci.2013.07.006","article-title":"Natural killer cell biology: an update and future directions","volume":"132","author":"Campbell","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"10","key":"10.1016\/j.tranon.2023.101816_bib0048","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1182\/blood-2004-10-4113","article-title":"NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect","volume":"105","author":"Nguyen","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.tranon.2023.101816_bib0049","first-page":"182","article-title":"Tumor-induced perturbations of cytokines and immune cell networks","volume":"1845","author":"Burkholder","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"8","key":"10.1016\/j.tranon.2023.101816_bib0050","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00262-012-1210-z","article-title":"Harnessing human plasmacytoid dendritic cells as professional APCs","volume":"61","author":"Tel","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.tranon.2023.101816_bib0051","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11845-016-1464-0","article-title":"Dymicka-Piekarska V. From inflammation to cancer","volume":"186","author":"Korniluk","year":"2017","journal-title":"Ir. J. Med. Sci."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523323002024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523323002024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:28:57Z","timestamp":1761845337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523323002024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":51,"alternative-id":["S1936523323002024"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2023.101816","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive analysis of ASB3 as a prognostic biomarker in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2023.101816","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101816"}}